Cafepharma Today

April 19 2024 - Roche wins FDA OK for targeted drug in early lung cancer
Roche wins FDA OK for targeted drug in early lung cancer
How Vir found the one: CEO Marianne De Backer
Ozempic's latest reported side effect: pregnancy
FDA mandates label updates on CAR-T cancer therapies
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Brand managers reflect on historic launch of Wegovy
Medical Marketing and Media
Monday, April 8, 2024 - 12:01pm
tags:
Novo Nordisk, Wegovy, obesity, drug launches, brand management
Oral vaccine for UTI is potential alternative to antibiotics, finds 9-year study
Medical Xpress
Monday, April 8, 2024 - 12:00pm
tags:
Immunotek, UTIs, vaccines, MV140
The Next Wave of ADCs Could Treat Evasive Solid Tumors
BioSpace
Monday, April 8, 2024 - 11:57am
tags:
antibody-drug conjugate, AACR, solid tumors, Elevation Oncology, Tubulis
Why AbbVie is making big bets on telling the story of its R&D investments
Medical Marketing and Media
Monday, April 8, 2024 - 11:56am
tags:
AbbVie, R&D
FDA grants breakthrough status to Dizal’s sunvozertinib
Pharmaceutical Business Review
Monday, April 8, 2024 - 11:54am
tags:
Dizal Pharmaceutical, FDA, non-small cell lung cancer, sunvozertinib
Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial
Reuters
Monday, April 8, 2024 - 11:22am
tags:
brain implants, Medtech, Synchron, Neuralink, clinical trials
Jardiance doesn’t cut it in post-heart attack trial
Pharmaphorum
Monday, April 8, 2024 - 11:21am
tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, clinical trials, heart attack
FDA swats away Supernus’ Parkinson’s disease infusion pump for 3rd time
Fierce Pharma
Monday, April 8, 2024 - 11:07am
tags:
Medtech, FDA, Supernus, Parkinson's Disease
Boston Scientific initiates study for PFA catheter system
Clinical Trials Arena
Monday, April 8, 2024 - 10:52am
tags:
Boston Scientific, Medtech, clinical trials, PFA catheter, atrial fibrillation
ACC: Ionis' rare metabolic disorder drug slides from 100% efficacy, but FDA ambitions unchanged
Fierce Biotech
Monday, April 8, 2024 - 10:50am
tags:
Ionis Pharmaceuticals, clinical trials, olezarsen, familial chylomicronemia syndrome
FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers
Investing.com
Sunday, April 7, 2024 - 4:45pm
tags:
AstraZeneca, Daiichi Sankyo, FDA, Enhertu, solid tumors
Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studies
Reuters
Sunday, April 7, 2024 - 4:42pm
tags:
Bristol Myers Squibb, schizophrenia, clinical trials, KarXT
Geneos cancer vaccine shrinks liver tumors in small trial
Reuters
Sunday, April 7, 2024 - 4:40pm
tags:
Geneos, vaccines, liver cancer, clinical trials
J&J scoops up cardio medtech Shockwave Medical for $13.1B
Medical Marketing and Media
Friday, April 5, 2024 - 11:54am
tags:
JNJ, M&A, Medtech, Shockwave Medical, Cardiovascular, intravascular lithotripsy
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
BioSpace
Friday, April 5, 2024 - 11:52am
tags:
Novo Nordisk, M&A, Catalent, SEC
FDA grants de novo nod to AI tool for detecting sepsis
Medtech Dive
Friday, April 5, 2024 - 11:49am
tags:
Medtech, Prenosis, sepsis, De Novo, artificial intelligence, Sepsis Immunoscore
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS
BioSpace
Friday, April 5, 2024 - 11:42am
tags:
Merck, clinical trials, KRAS inhibitors, MK-1084, non-small lung cancer
FDA allows expanded use of Bristol Myers' cell therapy for blood cancer
Reuters
Friday, April 5, 2024 - 11:40am
tags:
Bristol Myers Squibb, 2seventybio, Abecma, cell therapy
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
BioSpace
Friday, April 5, 2024 - 11:37am
tags:
Novartis, Pluvicto, prostate cancer, clinical trials, radioligands
House committee to press FDA Commissioner Robert Califf on shortage oversight, other issues
Fierce Pharma
Friday, April 5, 2024 - 11:36am
tags:
FDA, Robert Califf, drug shortages

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Pharmaceutical Sales- Associate Territory Manager- Primary Care
Washington DC, 20066
Eli Lilly and Company
Sales Representative
Nampa, ID, 83651
Bartlett Roofing
Pharmaceutical Sales Representative (PSR)
Iowa City, IA, 52246
Syneos Health, Inc
Diagnostics Hematology Specialist (Michigan)
Michigan, ND, 58259
Adaptive Biotechnologies
Professional Pharmaceutical Sales Representative
Pueblo, CO, 81001
Syneos Health, Inc
Pharmaceutical Sales- Associate Territory Manager- Primary Care
Covington, Georgia
Eli Lilly and Company
Manager, Inside Sales
Austin, TX
AbbVie
Vice President of Sales
Durham, NC
Confidential
Aesthetic Surgical Rep -Allergan Aesthetics, Richmond/Virginia Beach, VA
Richmond, VA, 23234
AbbVie, Inc
Generic Pharmaceuticals Inside Sales Representative
Cincinnati, OH, 45201
BluPax Pharma
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information